WATERTOWN, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), today announced positive interim data from the Phase 1b acute hemodynamic clinical ...

Am J Health Syst Pharm. 2010;67(5):351-360. In the ESCAPE-1 trial, which assessed clevidipine's preoperative antihypertensive effects, the types and rates of adverse effects were similar for each ...